Nebius shares surged 34% following a quarterly report showing a 454% revenue increase to $582 million and a reduced loss per share of $0.12. This strong performance led several analysts, including those from Bank of America and Baird, to raise their 12-month price targets significantly, with some forecasts reaching as high as $410. Despite the enthusiasm, Morgan Stanley issued a more cautious 'Hold' rating with a lower target of $144, reflecting concerns about high technology costs and uncertain returns in the AI sector. The rally also helped revive interest in AI stocks amid broader market gains, though some investors remain wary of the sector's risks.
Anthropic, an AI company, is targeting an October IPO with a valuation of $2 trillion or more, which would surpass SpaceX's recent $1.77 trillion debut. Investors expect the company's revenue to jump from $47 billion to over $100 billion within a yea...
Equity markets continue to rise driven by optimism around AI, with companies like CoreWeave and Nebius posting strong quarterly results. However, credit markets are showing signs of increasing stress, particularly in private credit and commercial rea...
President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...
Nebius exceeded expectations in its Q2 earnings, driven by rapid growth in its cloud computing base and high demand for GPUs. The company raised its cloud capacity forecast for the current fiscal year by 25% to 5 GW, signaling strong expansion. Nebiu...
CoreWeave (CRWV) is rated Buy, favored for its larger scale, lower reliance on prepayment funding, and stronger cash flow, which reduce cash burn and improve return on invested capital compared to Nebius (NBIS), rated Sell. Although Nebius trades at ...
